Search research articles
Contact Us
Filters
Showing results (21-30 of 73) with videos related to
Page
of 8
Sort By:
Expert Opinion on Drug Discovery
|
September 7, 2020
What are the practical, ethical, and pathobiological considerations in the use of minipigs as an animal model in drug discovery for acute radiation syndrome and delayed effects of acute radiation exposure?
Doreswamy Kenchegowda, Thomas M Seed, Vijay K Singh
Expert Opinion on Drug Discovery
|
August 17, 2021
What are the practical, ethical and pathobiological considerations in the use of minipigs as an animal model in drug discovery for acute radiation syndrome and delayed effects of acute radiation exposure?
Doreswamy Kenchegowda, Thomas M Seed, Vijay K Singh
Drug Discovery Today
|
October 13, 2025
Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries
Vijay K Singh, Arthur Machlenkin, Thomas M Seed
Expert Review of Proteomics
|
September 26, 2023
Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions
Vijay K Singh, Meera Srivastava, Thomas M Seed
Cytokine
|
September 13, 2014
Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review
Vijay K Singh, Victoria L Newman, Thomas M Seed
International Journal of Radiation Biology
|
March 7, 2014
Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis
Thomas M Seed, Cynthia E Inal, Vijay K Singh
Journal of Radiation Research
|
May 10, 2013
Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures
Vijay K Singh, Lindsay A Beattie, Thomas M Seed
Expert Review of Molecular Diagnostics
|
May 24, 2021
Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives
Vijay K Singh, Thomas M Seed, Amrita K Cheema
Expert Opinion on Drug Discovery
|
April 23, 2019
Drug discovery strategies for acute radiation syndrome
Vijay K Singh, Thomas M Seed, Ayodele O Olabisi
Health Physics
|
April 24, 2015
Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile
Vijay K Singh, Patricia L P Romaine, Thomas M Seed
Page
of 8
Search research articles
Search
Showing results (21-30 of 73) with videos related to
Sort By:
Page
of 8
Expert Opinion on Drug Discovery
|
September 7, 2020
What are the practical, ethical, and pathobiological considerations in the use of minipigs as an animal model in drug discovery for acute radiation syndrome and delayed effects of acute radiation exposure?
Doreswamy Kenchegowda, Thomas M Seed, Vijay K Singh
Expert Opinion on Drug Discovery
|
August 17, 2021
What are the practical, ethical and pathobiological considerations in the use of minipigs as an animal model in drug discovery for acute radiation syndrome and delayed effects of acute radiation exposure?
Doreswamy Kenchegowda, Thomas M Seed, Vijay K Singh
Drug Discovery Today
|
October 13, 2025
Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries
Vijay K Singh, Arthur Machlenkin, Thomas M Seed
Expert Review of Proteomics
|
September 26, 2023
Protein biomarkers for radiation injury and testing of medical countermeasure efficacy: promises, pitfalls, and future directions
Vijay K Singh, Meera Srivastava, Thomas M Seed
Cytokine
|
September 13, 2014
Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review
Vijay K Singh, Victoria L Newman, Thomas M Seed
International Journal of Radiation Biology
|
March 7, 2014
Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis
Thomas M Seed, Cynthia E Inal, Vijay K Singh
Journal of Radiation Research
|
May 10, 2013
Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures
Vijay K Singh, Lindsay A Beattie, Thomas M Seed
Expert Review of Molecular Diagnostics
|
May 24, 2021
Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives
Vijay K Singh, Thomas M Seed, Amrita K Cheema
Expert Opinion on Drug Discovery
|
April 23, 2019
Drug discovery strategies for acute radiation syndrome
Vijay K Singh, Thomas M Seed, Ayodele O Olabisi
Health Physics
|
April 24, 2015
Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile
Vijay K Singh, Patricia L P Romaine, Thomas M Seed
Page
of 8